An increase in mRNA levels of IL-2, IL-12p40, IL-12p70, and IL-15 correlated with their increased protein levels in splenocytes of bortezomib-treated tumor-bearing mice compared with untreated tumor-bearing mice (Figure 2). This evidence concerns the gene IL15 and neoplasm.